DUBLIN--(BUSINESS WIRE)--The "Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2023-2027)" report has been added to ResearchAndMarkets.com's offering.
The global interventional pulmonology market is forecasted to reach US$4.95 billion in 2027, rising at a CAGR of 5.80%, for the time period of 2023-2027.
Factors such as growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness would drive the growth of the market.
However, the market growth would be challenged by associated patients risk, high cost involved in the maintenance of equipment and entry barriers for new companies.
A few notable trends may include rising healthcare expenditures, growing consumption of e-cigarettes and improving training programs for interventional pulmonologist.
Robotic bronchoscopy is emerging as a game changer in the interventional pulmonology market. Rapid and accurate diagnosis of lung cancer have become the need of the hour in the interventional pulmonology market.
This is triggering the developments in robotic bronchoscopy platforms, consisting of a hand-held controller used to direct a small, flexible endoscope into the lung using a computer-assisted navigation. As a result of such developments, the overall global interventional pulmonology market would aid in near future.
China is emerging out as a prominent region in the global market due to accelerating aging population and changing disease patterns, along with the escalating demands from healthcare institutions.
Other factors such as strong government policy support, continuous technology innovation and increasing public awareness are further likely to accelerate the market growth in the region and thereby would add to the overall global interventional pulmonology market in coming years.
Scope of the report
- The report provides a comprehensive analysis of the global interventional pulmonology market.
- The major regional markets (China, the U.S., Europe and ROW) have been analyzed.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The company profiles of leading players (Johnson & Johnson, Pulmonx Corporation, Medtronic PLC, FUJIFILM Holdings Corporation, Boston Scientific Corporation and Olympus Corporation) are also presented in detail.
Report Metrics:
| Report Attribute | Details |
| No. of Pages | 66 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value (USD) in 2023 | $3.95 Billion |
| Forecasted Market Value (USD) by 2027 | $4.95 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
Key Topics Covered:
1. Market Overview
2. Impact of COVID-19
2.1 Proposed Triage of Interventional Pulmonology Procedures During COVID-19.
2.2 Rise in Adoption of Healthcare Artificial Intelligence
2.3 Role of Single-use Bronchoscopes in COVID-19
3. Global Market Analysis
3.1 Global Interventional Pulmonology Market by Value
3.2 Global Interventional Pulmonology Market Forecast by Value
3.3 Global Interventional Pulmonology Market by Product
3.3.1 Global Electromagnetic Navigation Bronchoscopy Products Market by Value
3.3.2 Global Electromagnetic Navigation Bronchoscopy Products Market Forecast by Value
3.3.3 Global Interventional Pulmonology Diagnostics Products Market by Value
3.3.4 Global Interventional Pulmonology Diagnostics Products Market Forecast by Value
3.3.5 Global Interventional Pulmonology Therapeutic Products Market by Value
3.3.6 Global Interventional Pulmonology Therapeutic Products Market Forecast by Value
3.4 Global Bronchoscopy Procedure Volume
3.5 Global Bronchoscopy Procedure Volume Forecast
3.6 Global Bronchoscopy Procedure Volume by Region
4. Regional Market Analysis
4.1 China
4.1.1 China Interventional Pulmonology Navigation Device Market by Value
4.1.2 China Interventional Pulmonology Navigation Device Market Forecast by Value
4.1.3 China Interventional Pulmonology Navigation Device Market Forecast by Volume
4.1.4 China Bronchoscopy Procedure Volume
4.1.5 China Bronchoscopy Procedure Volume Forecast
4.2 The U.S.
4.2.1 The U.S. Bronchoscopy Procedure Volume
4.2.2 The U.S. Bronchoscopy Procedure Volume Forecast
4.3 Europe
4.3.1 Europe Bronchoscopy Procedure Volume
4.3.2 Europe Bronchoscopy Procedure Volume Forecast
4.4 ROW
4.4.1 ROW Bronchoscopy Procedure Volume
4.4.2 ROW Bronchoscopy Procedure Volume Forecast
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Growing Incidence of Lung Cancer
5.1.2 Rising CO2 Emission
5.1.3 Expansion of Medical Device Industry
5.1.4 Surging COPD Mortality Rate
5.1.5 Increasing Elderly Population
5.1.6 Increasing Public Awareness
5.2 Key Trends & Developments
5.2.1 Rising Healthcare Expenditure
5.2.2 Growing Consumption of E-cigarettes
5.2.3 Improving Training Programs for Interventional Pulmonologist
5.3 Challenges
5.3.1 Associated Patient Risk
5.3.2 High Cost Involved in the Maintenance of Equipment
5.3.3 Entry Barrier for New Companies
6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Business Overview
6.2 Pulmonx Corporation
6.2.1 Business Overview
6.3 Medtronic PLC
6.3.1 Business Overview
6.4 FUJIFILM Holdings Corporation
6.4.1 Business Overview
6.5 Boston Scientific Corporation
6.5.1 Business Overview
6.6 Olympus Corporation
6.6.1 Business Overview
For more information about this report visit https://www.researchandmarkets.com/r/6g3qzj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
